Neurology Advisor16h
Methylphenidate May Improve Sleep Outcomes in ADHD Without Dysregulation Profile
Methylphenidate treatment in children with ADHD with dysregulation profile is associated with worse sleep outcomes.
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025
Results Have Been Submitted Ahead of In-Person Meeting with FDA Set for April 2CTx-1301 is the First, True, Once-Daily Stimulant Medication to ...